This paper is in the following e-collection/theme issue:

Discretionary Corrigenda (19)

Published on in Vol 10, No 4 (2022): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38505, first published .
Correction: Mining Electronic Health Records for Drugs Associated With 28-day Mortality in COVID-19: Pharmacopoeia-wide Association Study (PharmWAS)

Correction: Mining Electronic Health Records for Drugs Associated With 28-day Mortality in COVID-19: Pharmacopoeia-wide Association Study (PharmWAS)

Correction: Mining Electronic Health Records for Drugs Associated With 28-day Mortality in COVID-19: Pharmacopoeia-wide Association Study (PharmWAS)

Authors of this article:

Ivan Lerner1, 2, 3 Author Orcid Image ;   Arnaud Serret-Larmande1, 2 Author Orcid Image ;   Bastien Rance1, 3 Author Orcid Image ;   Nicolas Garcelon3, 4 Author Orcid Image ;   Anita Burgun1, 2, 3 Author Orcid Image ;   Laurent Chouchana5 Author Orcid Image ;   Antoine Neuraz1, 2, 3 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics

    Corrigenda and Addenda

    1Inserm, Centre de Recherche des Cordeliers, Sorbonne Université, Paris, France

    2Informatique biomédicale, Hôpital Necker-Enfants Malades, Assistance Publique - Hôpitaux de Paris, Paris, France

    3HeKA Team, Inria, Paris, France

    4Inserm UMR 1163, Data Science Platform, Université de Paris, Imagine Institute, Paris, France

    5Centre Régional de Pharmacovigilance, Service de Pharmacologie, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Centre - Université de Paris, Paris, France

    Corresponding Author:

    Antoine Neuraz, MD, PhD

    Inserm

    Centre de Recherche des Cordeliers

    Sorbonne Université

    Université de Paris

    15 Rue de l'École de Médecine

    Paris, 75006

    France

    Phone: 33 01 44 27 64 82

    Email: antoine.neuraz@aphp.fr



    In “Mining Electronic Health Records for Drugs Associated With 28-day Mortality in COVID-19: Pharmacopoeia-wide Association Study (PharmWAS)” (JMIR Med Inform 2022;10(3):e35190), the following corrections were made.

    1. In the Results section of the abstract, a Q-value was incorrectly written as follows:

    Among these, diazepam and tramadol were the only ones not discarded by automated diagnostics, with adjusted odds ratios of 2.51 (95% CI 1.52-4.16, Q=.1) and 1.94 (95% CI 1.32-2.85, Q=.02), respectively.

    This has been corrected to:

    Among these, diazepam and tramadol were the only ones not discarded by automated diagnostics, with adjusted odds ratios of 2.51 (95% CI 1.52-4.16, Q=.01) and 1.94 (95% CI 1.32-2.85, Q=.02), respectively.

    2. In the first paragraph of the discussion, the following sentence was incorrectly added as follows:

    Indeed, of 87 treatments prescribed in the first 48 hours, 4 (5%) were associated with increased 28-day mortality after adjustment of confounding factors and multiple testing correction, and none were associated with increased mortality.

    This has been corrected to:

    Indeed, of 87 treatments prescribed in the first 48 hours, 4 (5%) were associated with increased 28-day mortality after adjustment of confounding factors and multiple testing correction, and none were associated with decreased mortality.

    The correction will appear in the online version of the paper on the JMIR Publications website on April 12, 2022, together with the publication of this correction notice. Because this was made after submission to PubMed, PubMed Central, and other full-text repositories, the corrected article has also been resubmitted to those repositories.

    This is a non–peer-reviewed article. submitted 05.04.22; accepted 05.04.22; published 12.04.22.

    Copyright

    ©Ivan Lerner, Arnaud Serret-Larmande, Bastien Rance, Nicolas Garcelon, Anita Burgun, Laurent Chouchana, Antoine Neuraz. Originally published in JMIR Medical Informatics (https://medinform.jmir.org), 12.04.2022.

    This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Medical Informatics, is properly cited. The complete bibliographic information, a link to the original publication on https://medinform.jmir.org/, as well as this copyright and license information must be included.